PMA supplement
P190019 S018: Ranger™ Paclitaxel-Coated PTA Balloon Catheter
FDA PMA supplement · Real-Time Process · Boston Scientific Corporation
Key facts
| Original PMA | P190019 |
|---|---|
| Supplement number | S018 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | Ranger™ Paclitaxel-Coated PTA Balloon Catheter |
| Generic name | Drug-Eluting Peripheral Transluminal Angioplasty Catheter |
| Applicant | Boston Scientific Corporation |
| Product code | ONU |
| Received date | Dec 7, 2022 |
| Decision date | Mar 2, 2023 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: